jump to content jump to footer
Onur Özek from Mint Medical discusses the challenges, requirements, and future of lung cancer screening in Germany in an interview with RadMag.

RadMag Special Edition: Onur Özek on the Challenges of Lung Cancer Screening in Germany

With the nationwide rollout of Germany’s lung cancer screening, radiology providers are facing new challenges. Structured reporting, mandatory second readings, longitudinal follow-up, and AI integration must work seamlessly together to support high-quality patient care.

In the latest Radiologie Magazin Special Edition, Onur Özek, Managing Director of Mint Medical, discusses why lung cancer screening is far more than the interpretation of a single examination:

“Screening is a process – and it requires an end-to-end platform.”

In the interview, he explains the requirements that Germany’s screening program places on radiology, IT infrastructure, and organizational workflows, the role of structured reporting and AI, and why interoperability and integrated workflows are critical to the long-term success of screening networks.

“It is not enough to deploy individual technologies. What matters is that all processes work together seamlessly and are integrated into existing IT infrastructures such as RIS and PACS.”

Topics Covered in the Interview

What role does AI play in lung cancer screening?

AI supports the detection and analysis of pulmonary nodules. However, the key factor is the integration of AI-generated results into the clinical workflow.

Why is interoperability important?

Screening programs connect primary readers, second-reading centers, and registries. Without standardized data exchange, workflow disruptions and inefficiencies can occur.

How does mint Lesion support radiologists in lung cancer screening?

mint Lesion supports radiologists in addressing key requirements of lung cancer screening—from structured reporting and AI-supported analysis to second-reader workflows and the longitudinal follow-up of screening participants.

 

Read the full interview in the current RadMag Special Edition on lung cancer screening.

Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.
The two-day “RECIST and Beyond” workshop at radCIO Cologne offered intensive hands-on training on RECIST, iRECIST, mRECIST and LI-RADS, with real-case reporting performed directly in mint Lesion.
Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging
How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?
Read more
Screenshot of the mint Lesion interface showing RANO 2.0 configuration, tumor burden calculations, and structured neuro-oncology assessment tools.
mint Lesion fully supports RANO 2.0 implementation with configurable parameters, automated tumor burden calculations, and structured workflows for neuro-oncology clinical trials.
Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion
Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…
Read more
Image of a patient getting an MRI scan, signifying how RACOON projects in Germany show how imaging, structured reporting, and AI jointly advance clinical research.
Overview of major RACOON projects in radiology and clinical research.
RACOON – Imaging, Data & Collaboration for Better Decisions
Modern radiology faces a central question: how can imaging and clinical data be combined in a way that leads to more precise diagnoses,…
Read more
scroll-top